Page 37 - CIRN Annual Report 2017
P. 37
LIST OF PUBLICATIONS, ABSTRACTS AND PRESENTATIONS
2010-2011 through 2013-2014. Canadian Immunization Conference, Ottawa ON. 2-4
CIRN • 2017 ANNUAL REPORT 35
T Hatchette, H Scholz, S Bolotin, N Crowcroft, C Jackson, E McLachlan, A Severini.
J Kwong, T Mazzulli, SA McNeil, M Muller, J Powis, A Simor, M Smieja, S Drews, AJ
BL Coleman , B Borgundvaag, TF Hatchette, L Holness, K Katz, J Langley, M Loeb,
adverse events following immunization (2013-2016). Poster presented at: Canadian
J Isenor, G De Serres; Canadian Immunization Research Network. CANVAS: Active
determining antibody immunity to measles virus. Canadian Immunization Research
McGeerJ. Seasonal influenza vaccine effectiveness in adults working in hospitals:
Clinic Network. Presented at: Canadian Immunization Conference 2016; 2016 Dec
J Bettinger, L Valiquette, B Coleman, K Top, O Vanderkooi, A McCarthy, J Kellner,
Loeb. The microneutralization assay is superior to the hemagglutination inhibition
vaccines, 2015 and 2016 [abstract]. In: Oral Abstracts of Canadian Immunization
CP Verschoor, P Singh, ML Russell, DME Bowdish, A Brewer, L Cyr, BJ Ward, M
Severini. Correlation of the BioPlex test and plaque reduction neutralization test
uenza
K Top. Immunizing immunocompromised patients in the Special Immunization
for determining antibody immunity to measles virus. Canadian Immunization
surveillance for adverse events following immunization with seasonal infl
Immunization Conference 2016; 2016 Dec 6–8; Ottawa, ON.
assay for the estimation of seroprotection against influenza infection in children. BL Coleman, SA Fadel, SJ Drews,TF Hatchette, AJ McGeer. Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial. Influenza Other Respir S Bolotin, T Hatchette, A Severini. Immunity of Canadians and Risk of Epidemics (iCARE): using sero-epidemiology to answer questions about population immunity
Conference 2016; 2016 Dec 6–8; Ottawa, ON. 7; Ottawa, ON. REFERENCE LABORATORY NETWORK T Hatchette, H Scholz, S Bolotin, N Crowcroft, C Jackson, E McLachlan, A Conference, December 2-4, 2014. Ottawa, ON. (Poster) December, 2014. Oral presentation. Correlation of the BioPlex test and Plaque Reduction Neutralization Test for Network 1st Annual Meeting, May 6-7th, 2015. Montreal, Quebec. (Poster) PLoS ONE 2015 Jun 24;10(6):e0131531. Viruses. 2015
D Tran, W Vaudry, S Dobson, FD Boucher, A Carignan, T Jadavji, A McConnell, SA
KA Top, M-N Billard, M-C Gariepy, I Rouleau, JM Pernica, A Pham-Huy, C Quach,
McNeil, SA Halperin, G De Serres G; Canadian Immunization Research Network’s
Oncology centers [Short Report]. Hum Vaccin Immunother. 2016;12(4):931–936.
(CIRN) Special Immunization Clinics Network investigators. Immunizing patients
and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/
immunization: A report from the Special Immunization Clinics Network. Pediatr
with adverse events following immunization and potential contraindications to
Infect Dis J. 2016;35(12):e384-e391. KA Top, G De Serres, M-C Gariepy, SA Halperin, FD Boucher, S Dobson, J Pernica, A Pham-Huy, C Quach, D Tran, W Vaudry, S McNeil. The Special Immunization Clinics Network to investigate patients with adverse events following immunization and potential contradictions to vaccination. AMMI Canada - CACMID Annual Conference, April 16-18, 2015. Charlottetown, PEI. JM Langley, DM MacDougall, BA Halperin, A Swain, SA